38
Views
3
CrossRef citations to date
0
Altmetric
Original article

Routine determination of serum methylmalonic acid and plasma total homocysteine in Norway

, &
Pages 355-367 | Received 05 Feb 2003, Accepted 25 Mar 2003, Published online: 08 Jul 2009

REFERENCES

  • Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, Marcell PD, Stabler SP, Allen RH. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318: 1720–8.
  • Norberg B, Almay B, Ernerudh J, Fehling C, Johansson B, Link H, Lundberg PO, Persson L, Tegner R. [Neurological institutes agree: they suggest new guidelines for handling of suspected vitamin B 12 deficiency]. Lakartidningen 1992; 89: 2011— 2.
  • Nexo E, Hansen M, Rasmussen K, Lindgren A, Grasbeck R. How to diagnose cobalamin defi-ciency. Scand J Clin Lab Invest 1994; Suppl. 219: 61–76.
  • Guidelines on the investigation and diagnosis of cobalamin and folate deficiencies.A publication of the British Committee for Standards in Haematol-ogy. BCSH General Haematology Test Force. Clin Lab Haematol 1994; 16: 101–15.
  • Lindgren A. [Evaluation of analytic test methods. Stomach-intestines status is the best diagnostic method in suspected vitamin B12 deficiency]. Lakartidningen 2000; 97: 3987— 92.
  • Lokk J, Nilsson M, Norberg B, Hultdin J, Sandstrom H, Westman G. Shifts in B12 opinions in primary health care of Sweden. Scand J Public Health 2001; 29: 122–8.
  • Rasmussen K, Moelby L, Jensen MK. Studies on methylmalonic acid in humans. II. Relationship between concentrations in serum and urinary excretion, and the correlation between serum cobalamin and accumulation of methylmalonic acid. Clin Chem 1989; 35: 2277–80.
  • Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr 1996; 126: 1266S–72S.
  • Hvas AM, Juul S, Gerdes LU, Nexo E. The marker of cobalamin deficiency, plasma methyl-malonic acid, correlates to plasma creatinine. J Intern Med 2000; 247: 507–12.
  • Rasmussen K, Vyberg B, Pedersen KO, Brochner-Mortensen J. Methylmalonic acid in renal insuffi-ciency: evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990; 36: 1523–4.
  • Matthews JH. Cobalamin and folate deficiency in the elderly. Baillieres Clin Haematol 1995; 8: 679–97.
  • Zittoun J, Zittoun R. Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol 1999; 36: 35–46.
  • Allen RH, Stabler SP, Savage DG, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. Faseb J 1993; 7: 1344–53.
  • Ueland P, Refsum H, Schneede J. Determinants of Plasma homocysteine. In: Robinson K, editor. Homocysteine and vascular disease. Dordrecht: Kluwer Academic Publishers; 2000. P. 59–84
  • Rasmussen K, Moller J. Total homocysteine measurement in clinical practice. Ann Clin Biochem 2000; 37: 627–48.
  • Honeland G, Schneede J, Ueland PM, Lund PK, Refsum H, Sandberg S. Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnos-tic strategies. Clin Chem 1999; 45: 189–98.
  • Hvas AM, Ellegaard J, Nexo E. Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med 2001; 161: 1534–41.
  • Hvas AM, Vestergaard H, Gerdes LU, Nexo E. Physicians' use of plasma methylmalonic acid as a diagnostic tool. J Intern Med 2000; 247: 311–7.
  • Hvas AM, Lous J, Ellegaard J, Nexo E. Use of plasma methylmalonic acid in diagnosing vitamin B-12 deficiency in general practice. Scand J Prim Health Care 2002; 20: 57–9.
  • Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996; 42: 630–6.
  • Chanarin I, Metz J. Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol 1997; 97: 695–700.
  • Kjxrstad SI. [Use of homocysteine and methyl-malonic acid in diagnosis of B12-deficiency]. Semesteroppgave. Oslo: Hoyskoleni Oslo, Avdel-ing for Helsefag, Bioingeniorutdanningen; 1998. p. 1–55.
  • Kjxrstad S, Schneede J. Experiences with the use of homocysteine and methylmalonic acid in the diagnosis of cobalamin deficiency. Bioingenioeren 1999; 12: 4–8.
  • Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample sta-bility. Clin Chem 1993; 39: 263–71.
  • Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989; 35: 1921–7.
  • Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applica-tions. Clin Chem 1993; 39: 1764–79.
  • Schneede J, Ueland PM. Application of capillary electrophoresis with laser-induced fluorescence detection for routine determination of methylmalonic acid in human serum. Anal Chem 1995; 67: 812–9.
  • Husek P, Matucha P. Simple approach for analysis of plasma oxo-, hydroxy- and dicar-boxylic acids. J Chromatogr B Biomed Sci Appl 1997; 693: 499–502.
  • Moller J, Rasmussen K, Christensen L. External quality assessment of methylmalonic acid and total homocysteine. Clin Chem 1999; 45: 1536–42.
  • Fokkema MR, Weijer JM, Dijck-Brouwer DA, van Doormaal JJ, Muskiet FA. Influence of vitamin-optimized plasma homocysteine cut-off values on the prevalence of hyperhomocysteinemia in healthy adults. Clin Chem 2001; 47: 1001–7.
  • Rajan S, Wallace JI, Beresford SA, Brodkin KI, Allen RA, Stabler SP. Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc 2002; 50: 624–30.
  • Hjelt K, Brynskov J, Hippe E, Lundstrom P, Munck O. Oral contraceptives and the cobalamin (vitamin B12) metabolism. Acta Obstet Gynecol Scand 1985; 64: 59–63.
  • Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999; 69: 482–9.
  • Koehler KM, Romero LJ, Stauber PM, Pareo-Tubbeh SL, Liang HC, Baumgartner RN, Garry PJ, Allen RH, Stabler SP. Vitamin supplementa-tion and other variables affecting serum homo-cysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 1996; 15: 364–76.
  • Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C. Serum cobalamin, homo-cysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnorm-alities. Am J Clin Nutr 1999; 70: 904–10.
  • Herrmann W, Schorr H, Geisel J, Riegel W. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med 2001; 39: 739–46.
  • Tsutsumi Y, Deguchi T, Takano M, Takadate A, Lindup WE, Otagiri M. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. J Pharmacol Exp Ther 2002; 303: 880–7.
  • Lindgren A. Elevated serum methylmalonic acid. How much comes from cobalamin deficiency and how much comes from the kidneys? Scand J Clin Lab Invest 2002; 62: 15–9.
  • Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing coba-lamin and folate deficiencies. Am J Med 1994; 96: 239–46.
  • Guttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollset SE, Refsum H. Determi-nants and vitamin responsiveness of intermediate hyperhomocysteinemia ( > or = 40 micromol/liter). The Hordaland Homocysteine Study. J Clin Invest 1996; 98: 2174–83.
  • Herrmann W, Geisel J. Vegetarian lifestyle and monitoring of vitamin B-12 status. Clin Chim Acta 2002; 326: 47–59.
  • Rydlewicz A, Simpson JA, Taylor RJ, Bond CM, Golden MH. The effect of folic acid supplementa-tion on plasma homocysteine in an elderly population. QJM 2002; 95: 27— 35.
  • Elian KM, Hoffer U. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease. Metabolism 2002; 51: 881–6.
  • Bjorke Monsen AL, Ueland PM, Vollset SE, Guttormsen AB, Markestad T, Solheim E, Refsum H. Determinants of cobalamin status in newborns. Pediatrics 2001; 108: 624–30.
  • Bondevik GT, Schneede J, Refsum H, Lie RT, Ulstein M, Kvale G. Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr 2001; 55: 856 — 64.
  • Hoverstad T, Bjorneklett A, Fausa O, Midtvedt T. Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol 1985; 20: 492–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.